Literature DB >> 3675096

What is the clinical significance of bone loss in primary hyperparathyroidism?

G Kochersberger1, N J Buckley, G S Leight, S Martinez, S Studenski, J Vogler, K W Lyles.   

Abstract

To help determine the clinical significance of the bone loss associated with primary hyperparathyroidism, we studied the prevalence of vertebral fractures in a group of patients with this disorder. From a registry of parathyroidectomies, 206 cases were reviewed, and lateral chest roentgenograms were studied for the presence of fractures. All roentgenograms were interpreted by two of the investigators who were "blinded" to diagnoses. Comparisons of readings were made that assured interrater agreement. A group of patients who underwent cholecystectomy served as controls. Studied in a logistic regression analysis model, controlling for the effects of age, sex, and race, primary hyperparathyroidism was found to be significantly associated with vertebral fractures. Subgroup analyses performed on the patients with hyperparathyroidism failed to identify specific biochemical or clinical markers associated with fractures. Our results suggest that the bone loss of primary hyperparathyroidism is clinically significant, leading not only to decreased bone densities but also to an increased prevalence of fractures.

Entities:  

Mesh:

Year:  1987        PMID: 3675096

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

Review 1.  Primary hyperparathyroidism: pathophysiology and impact on bone.

Authors:  A Khan; J Bilezikian
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

2.  Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism.

Authors:  I-Te Lee; Wayne Huey-Herng Sheu; Shih-Te Tu; Shi-Wen Kuo; Dee Pei
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

3.  Treatment for mild hyperparathyroidism.

Authors:  S Minisola; V Carnevale; F Bigi
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-04

4.  Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.

Authors:  P Vestergaard; C L Mollerup; V G Frøkjaer; P Christiansen; M Blichert-Toft; L Mosekilde
Journal:  BMJ       Date:  2000-09-09

Review 5.  Asymptomatic primary hyperparathyroidism.

Authors:  J C Birkenhäger; R Bouillon
Journal:  Postgrad Med J       Date:  1996-06       Impact factor: 2.401

Review 6.  Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy.

Authors:  Mishaela R Rubin; Shonni J Silverberg
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

Review 7.  What symptom improvement can be expected after operation for primary hyperparathyroidism?

Authors:  Nadine R Caron; Janice L Pasieka
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

8.  Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture.

Authors:  S Ljunghall; P Hellman; J Rastad; G Akerström
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

9.  Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism.

Authors:  Edda Vignali; Giuseppe Viccica; Daniele Diacinti; Filomena Cetani; Luisella Cianferotti; Elena Ambrogini; Chiara Banti; Romano Del Fiacco; John P Bilezikian; Aldo Pinchera; Claudio Marcocci
Journal:  J Clin Endocrinol Metab       Date:  2009-04-28       Impact factor: 5.958

10.  The Risk of Fractures in Primary Hyperparathyroidism: A Meta-Analysis.

Authors:  Niya Narayanan; Rajan Palui; Chandhana Merugu; Sitanshu Sekhar Kar; Sadishkumar Kamalanathan; Jayaprakash Sahoo; Sandhiya Selvarajan; Dukhabandhu Naik
Journal:  JBMR Plus       Date:  2021-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.